Skip to main content

Table 1 The characteristics of systemic lupus erythematosus (SLE) patients included in the study (n = 134). S.D., standard deviation; ANA, anti-nuclear antibody

From: High prevalence of protein tyrosine phosphatase non-receptor N22 gene functional variant R620W in systemic lupus erythematosus patients from Kuwait: implications for disease susceptibility

Gender ratio (Female: Male)

11: 1 (123/11)

Mean age (± S.D.), years

36.7 (±  9.3)

Mean age at diagnosis (± S.D.), years

30.6 (±  8.3)

Mean disease duration (range), months

48 (6–280)

Clinical manifestations: n (%)

Malar rash

73 (54.4)

Mouth ulcers

26 (19.4)

Photosensitivity

25 (18.7)

Discoid rash

9 (6.7)

Raynaud’s phenomenon

22 (16.4)

Arthritis

128 (95.5)

Serositis

29 (21.6)

Renal involvement

22 (16.4)

Hematological abnormalities

51 (38)

Neurological disorders

5 (3.7)

Immunological abnormalitiesa

95 (70.9)

ANAb

134 (100)

Hypertensionc

7 (5.2)

  1. aAs per criteria of the American College of Rheumatology (ACR) [23]
  2. bA standard indirect immunofluorescence method was used for detection and ascertainment as per ACR criteria and cutoff limits [23]
  3. cBlood Pressure > 140/90 mmHg (or > 130/80 mmHg in the case of renal insufficiency)